⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients With Classical Hodgkin Lymphoma

Official Title: A Prospective Phase II Study Of Nivolumab Alone, Or In Combination With Vinblastin In Patients Aged 61 Years And Older, With Classical Hodgkin Lymphoma And Coexisting Medical Conditions.

Study ID: NCT03580408

Interventions

Nivolumab
Vinblastin

Study Description

Brief Summary: This study is a multicentric phase II open-label trial consisting of 6 cycles Nivolumab (2 weeks interval) followed by a PET-CT scan. The treatment will be allocated according to PET and CT scan responses. : * In case of CMR according to Lugano Classification (Cheson et al.2014, PET-CT based response), patients will receive 18 additional cycles of Nivolumab, according to CT-based response at Cycle 12. * In case of Partial Metabolic Response (PMR) or No Metabolic Response(NMR), according to Lugano Classification (Cheson et al.2014, PET-CT based response) patients will receive 12 to 18 cycles of Nivolumab combined with Vinblastin according to CT-based response at Cycle 12. * In case of progressive disease, according to Lugano Classification (Cheson et al.2014, PET-CT scan based response) patients will be considered in treatment failure.

Detailed Description:

Eligibility

Minimum Age: 61 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

ZNA Stuivenberg, Antwerpen, , Belgium

Az Sint Jan, Bruges, , Belgium

Clinique Universitaire Saint LUC, Brussels, , Belgium

Institut Jules Bordet, Brussels, , Belgium

Hopital Jolimont, Haine saint paul, , Belgium

Az Groeninge, Kortrijk, , Belgium

CHU de Liege, Liege, , Belgium

CHU Dinant Godinne, Yvoir, , Belgium

CHU UCL Namur, Yvoir, , Belgium

CHU d'Amiens, Amiens, , France

CH d'Avignon - Hôpital Henri Duffaut, Avignon, , France

CH Côte Basque, Bayonne, , France

CHU de Besançon - Hôpital Jean Minjoz, Besançon, , France

Institut Bergonié - Bordeaux, Bordeaux, , France

Institut d'Hématologie de Basse Normandie - CHU Côte de Nacre, Caen, , France

CH Métropole Savoie, Chambery, , France

CHU de Clermont Ferrand, Clermont Ferrand, , France

CH Sud Francilien de Corbeil, Corbeil Essonnes, , France

APHP-Hôpital Henri Mondor, Créteil, , France

CHU de Dijon - Hôpital le Bocage, Dijon, , France

CHU de Grenoble, Grenoble, , France

CHD de Vendée, La Roche-sur-Yon, , France

CH La Rochelle, La Rochelle, , France

CH du Mans, Le Mans, , France

CH Saint Vincent de Paul, Lille, , France

CHRU de LILLE - Claude Huriez, Lille, , France

CHU de Limoges, Limoges, , France

Centre Leon Berard, Lyon Cedex 8, , France

Institut Paoli Calmette, Marseille, , France

CHRU de Metz-Thionville, Metz, , France

CHU de Montpellier - Saint Eloi, Montpellier, , France

CHU de Nantes - Hôtel Dieu, Nantes, , France

CHU de Nîmes - Caremeau, Nimes, , France

APHP - Hôpital Saint Louis, Paris Cedex 10, , France

APHP - Hopital Necker, Paris, , France

APHP - Hôpital de la Pitié Salpetrière, Paris, , France

Centre François Magendie - Hôpital du Haut Lévêque, Pessac, , France

CHU Lyon Sud, Pierre-Bénite, , France

CHU de Poitiers - Hôpital de La Milétrie, Poitiers, , France

Ch Rene Dubos, Pontoise, , France

Centre Hospitalier Annecy-Genevois - Site d'Annecy, Pringy, , France

CHU Robert Debré, Reims, , France

CHU de Rennes - Hôpital Pontchaillou, Rennes, , France

CH de Roubaix, Roubaix, , France

Centre Henri Becquerel, Rouen, , France

CH de Saint Brieuc, Saint-Brieuc, , France

CHRU de Strasbourg, Strasbourg, , France

IUCT Toulouse, Toulouse, , France

CHU Bretonneau, Tours, , France

CHU Brabois, Vandoeuvre les Nancy, , France

Institut Gustave Roussy, VILLEJUIF Cedex, , France

Contact Details

Name: Vincent RIBRAG

Affiliation: Institut Gustave Roussy Cancer, Villejuif, France - LYSA

Role: STUDY_CHAIR

Name: Julien LAZAROVICI

Affiliation: Institut Gustave Roussy Cancer, Villejuif, France - LYSA

Role: STUDY_CHAIR

Name: Marc ANDRE

Affiliation: CHU Dinant Godinne, UCL Namur, Yvoir - Belgium - LYSA

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: